Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Harmonized Hyperpolarized 129Xe MRI for Noninvasive Assessment of Pulmonary Hypertension in Interstitial Lung Disease and Systemic Sclerosis (ILD-PH/SSc)

NCT07821398 is registered in ClinicalTrials.gov with Bastiaan Driehuys as lead sponsor.

NCT NCT07821398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07821398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Harmonized Hyperpolarized 129Xe MRI for Noninvasive Assessment of Pulmonary Hypertension in Interstitial Lung Disease and Systemic Sclerosis (ILD-PH/SSc)
Lead sponsor
Bastiaan Driehuys
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
April 20, 2030
Enrollment
51 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, pulmonary hypertension, systemic sclerosis